The Tivozanib Timeline

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

December 2008, May 2009

End-of-phase II meetings between AVEO Pharmaceuticals Inc. and FDA result in agreement concerning the design of the phase III trial of tivozanib for advanced renal cell carcinoma.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I was really excited to get to talk about the role that mentorship plays in womenā€™s leadership development. Itā€™s a topic that Iā€™ve thought a lot about, and also that Iā€™ve benefitted from, and that I think is not always applied with enough intention. There is an art to mentorship, and I want to share some of how that has helped me navigate career transitions and pivot to leadership roles.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login